Biogen Pharmachem Industries Limited (BOM:531752)
India flag India · Delayed Price · Currency is INR
0.2900
+0.0100 (3.57%)
At close: Nov 17, 2026

BOM:531752 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
4.858.6-2.9319.314.56-0.09
Other Operating Activities
-0-0----0
Change in Accounts Receivable
-----25.4
Change in Accounts Payable
----18.4-0.61
Change in Other Net Operating Assets
3.097.09-7.890.14-5.91-10.73
Operating Cash Flow
7.9415.68-10.8219.4517.0413.98
Operating Cash Flow Growth
-40.64%--14.09%21.89%-64.60%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Investment in Securities
-91.27-89.38-184.0134.1-1925.39
Investing Cash Flow
-11.46-95.63-326.19-20.56-16.59-13.23

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Issuance of Common Stock
-63357---
Financing Cash Flow
-63357---

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
--0--0--
Net Cash Flow
-3.52-16.9519.99-1.120.460.76

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Levered Free Cash Flow
1.899.32-7.332.2511.2716.58
Unlevered Free Cash Flow
1.899.32-7.332.2511.2716.58

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Income Tax Paid
0.970.97----
Change in Working Capital
3.097.09-7.890.1412.4914.07